165 related articles for article (PubMed ID: 10821206)
21. Effects of D1 and D2 dopamine receptor antagonists and catecholamine depleting agents on the locomotor stimulation induced by dizocilpine in mice.
Lapin IP; Rogawski MA
Behav Brain Res; 1995 Oct; 70(2):145-51. PubMed ID: 8561905
[TBL] [Abstract][Full Text] [Related]
22. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
LaHoste GJ; Marshall JF
Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
[TBL] [Abstract][Full Text] [Related]
23. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis.
Jackson DM; Wallsten CE; Jerning E; Hu PS; Deveney AM
Psychopharmacology (Berl); 1998 Oct; 139(4):300-10. PubMed ID: 9809851
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of dopamine-mediated behaviour by the NMDA antagonists MK-801 and CPP: similarities with repeated electroconvulsive shock.
Smith SE; Acton L; Sharp T
Psychopharmacology (Berl); 1997 Sep; 133(1):85-94. PubMed ID: 9335085
[TBL] [Abstract][Full Text] [Related]
25. Changes in dopaminergic and glutamatergic excitatory mechanisms of micturition reflex after middle cerebral artery occlusion in conscious rats.
Yokoyama O; Yoshiyama M; Namiki M; de Groat WC
Exp Neurol; 2002 Jan; 173(1):129-35. PubMed ID: 11771945
[TBL] [Abstract][Full Text] [Related]
26. Apomorphine-induced behavioural sensitization in rats: individual differences, role of dopamine and NMDA receptors.
Võikar V; Soosaar A; Volke V; Kõks S; Bourin M; Männistö PT; Vasar E
Eur Neuropsychopharmacol; 1999 Dec; 9(6):507-14. PubMed ID: 10625119
[TBL] [Abstract][Full Text] [Related]
27. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
Neal-Beliveau BS; Joyce JN
Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
[TBL] [Abstract][Full Text] [Related]
28. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
29. Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors.
Czyrak A; Maćkowiak M; Fijał K; Chocyk A; Wedzony K
Pol J Pharmacol; 1997; 49(5):305-16. PubMed ID: 9566029
[TBL] [Abstract][Full Text] [Related]
30. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
Paul ML; Currie RW; Robertson HA
Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
[TBL] [Abstract][Full Text] [Related]
31. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
Cauli O; Morelli M
Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
[TBL] [Abstract][Full Text] [Related]
32. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies.
Hutson PH; Barton CL; Jay M; Blurton P; Burkamp F; Clarkson R; Bristow LJ
Neuropharmacology; 2000 Sep; 39(12):2318-28. PubMed ID: 10974315
[TBL] [Abstract][Full Text] [Related]
33. Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice.
Svensson A; Carlsson ML; Carlsson A
J Neural Transm Gen Sect; 1995; 101(1-3):127-48. PubMed ID: 8695043
[TBL] [Abstract][Full Text] [Related]
34. The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems.
Löscher W; Hönack D
Eur J Pharmacol; 1992 May; 215(2-3):199-208. PubMed ID: 1356790
[TBL] [Abstract][Full Text] [Related]
35. Chronic neonatal blockade of N-methyl-D-aspartate receptor by CGP 39551 increases dopaminergic function in adult rat.
Dall'Olio R; Facchinetti F; Contestabile A; Gandolfi O
Neuroscience; 1994 Nov; 63(2):451-5. PubMed ID: 7891857
[TBL] [Abstract][Full Text] [Related]
36. Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesions.
Boldry RC; Chase TN; Engber TM
J Pharmacol Exp Ther; 1993 Dec; 267(3):1454-9. PubMed ID: 7903390
[TBL] [Abstract][Full Text] [Related]
37. Chronic treatment with MK-801 affects the behavioral response to both D1 and D2 dopamine agonist in the one-trial inhibitory avoidance.
Mele A; Castellano C; Oliverio A
Psychopharmacology (Berl); 1995 Oct; 121(3):401-5. PubMed ID: 8584624
[TBL] [Abstract][Full Text] [Related]
38. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
Protais P; Lesourd M; Comoy E
Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
[TBL] [Abstract][Full Text] [Related]
39. Role of AMPA and NMDA receptors in the nucleus accumbens shell in turning behaviour of rats: interaction with dopamine receptors.
Ikeda H; Akiyama G; Fujii Y; Minowa R; Koshikawa N; Cools AR
Neuropharmacology; 2003 Jan; 44(1):81-7. PubMed ID: 12559124
[TBL] [Abstract][Full Text] [Related]
40. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
